NO20043613L - Genetisk polymorfi i preprotachykiningenet - Google Patents
Genetisk polymorfi i preprotachykiningenetInfo
- Publication number
- NO20043613L NO20043613L NO20043613A NO20043613A NO20043613L NO 20043613 L NO20043613 L NO 20043613L NO 20043613 A NO20043613 A NO 20043613A NO 20043613 A NO20043613 A NO 20043613A NO 20043613 L NO20043613 L NO 20043613L
- Authority
- NO
- Norway
- Prior art keywords
- preprotachykin
- gene
- genetic polymorphism
- polymorphism
- genetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Psychiatry (AREA)
- Pathology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02001937 | 2002-01-31 | ||
| PCT/EP2003/000630 WO2003064685A2 (en) | 2002-01-31 | 2003-01-23 | Genetic polymorphisms in the preprotachykinin gene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043613L true NO20043613L (no) | 2004-08-30 |
Family
ID=27635778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043613A NO20043613L (no) | 2002-01-31 | 2004-08-30 | Genetisk polymorfi i preprotachykiningenet |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20030158187A1 (no) |
| EP (1) | EP1472377A2 (no) |
| JP (1) | JP2005515788A (no) |
| KR (1) | KR20040077910A (no) |
| CN (1) | CN1625603A (no) |
| AR (1) | AR038334A1 (no) |
| BR (1) | BR0307257A (no) |
| CA (1) | CA2473128A1 (no) |
| GT (1) | GT200300020A (no) |
| HR (1) | HRP20040669A2 (no) |
| IL (1) | IL162733A0 (no) |
| MX (1) | MXPA04007353A (no) |
| NO (1) | NO20043613L (no) |
| PA (1) | PA8564401A1 (no) |
| PE (1) | PE20030816A1 (no) |
| PL (1) | PL371731A1 (no) |
| RU (1) | RU2004126440A (no) |
| TW (1) | TW200302729A (no) |
| UY (1) | UY27634A1 (no) |
| WO (1) | WO2003064685A2 (no) |
| ZA (1) | ZA200405516B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2572645C (en) | 2004-07-06 | 2011-01-18 | F. Hoffmann-La Roche Ag | Process for preparing carboxamide derivatives used as intermediates in the synthesis of nk-1 receptor antagonists |
| CN102449166B (zh) * | 2009-05-26 | 2013-12-04 | 厦门大学 | 一种单管检测多个单核苷酸变异或单核苷酸多态性的方法 |
| JP6317763B2 (ja) * | 2013-01-08 | 2018-04-25 | シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング | 対象における癌となる危険性を予測し又は癌と診断する方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8613431D0 (en) * | 1986-06-03 | 1986-07-09 | Medical Res Council | Human tachykinins |
| US5972938A (en) * | 1997-12-01 | 1999-10-26 | Merck & Co., Inc. | Method for treating or preventing psychoimmunological disorders |
| JP2002521061A (ja) * | 1998-07-25 | 2002-07-16 | アストラゼネカ・アクチエボラーグ | ヒトのニューロキニン２受容体遺伝子における遺伝多型、並びに疾患の診断および処置におけるそれらの使用 |
| ES2208205T3 (es) * | 1999-11-29 | 2004-06-16 | F. Hoffmann-La Roche Ag | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-otolil-piridin-3-il)-isobutiramida. |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
-
2003
- 2003-01-23 EP EP03734685A patent/EP1472377A2/en not_active Withdrawn
- 2003-01-23 CN CNA03803106XA patent/CN1625603A/zh active Pending
- 2003-01-23 WO PCT/EP2003/000630 patent/WO2003064685A2/en not_active Application Discontinuation
- 2003-01-23 MX MXPA04007353A patent/MXPA04007353A/es not_active Application Discontinuation
- 2003-01-23 RU RU2004126440/13A patent/RU2004126440A/ru not_active Application Discontinuation
- 2003-01-23 CA CA002473128A patent/CA2473128A1/en not_active Abandoned
- 2003-01-23 JP JP2003564275A patent/JP2005515788A/ja active Pending
- 2003-01-23 IL IL16273303A patent/IL162733A0/xx unknown
- 2003-01-23 PL PL03371731A patent/PL371731A1/xx not_active Application Discontinuation
- 2003-01-23 KR KR10-2004-7011752A patent/KR20040077910A/ko not_active Application Discontinuation
- 2003-01-23 BR BR0307257-6A patent/BR0307257A/pt not_active IP Right Cessation
- 2003-01-29 PA PA20038564401A patent/PA8564401A1/es unknown
- 2003-01-29 GT GT200300020A patent/GT200300020A/es unknown
- 2003-01-29 PE PE2003000097A patent/PE20030816A1/es not_active Application Discontinuation
- 2003-01-29 AR ARP030100256A patent/AR038334A1/es not_active Application Discontinuation
- 2003-01-30 UY UY27634A patent/UY27634A1/es not_active Application Discontinuation
- 2003-01-30 TW TW092102238A patent/TW200302729A/zh unknown
- 2003-01-30 US US10/354,693 patent/US20030158187A1/en not_active Abandoned
-
2004
- 2004-07-12 ZA ZA200405516A patent/ZA200405516B/en unknown
- 2004-07-20 HR HR20040669A patent/HRP20040669A2/hr not_active Application Discontinuation
- 2004-08-30 NO NO20043613A patent/NO20043613L/no unknown
-
2006
- 2006-06-21 US US11/472,083 patent/US20060228752A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL162733A0 (en) | 2005-11-20 |
| CN1625603A (zh) | 2005-06-08 |
| WO2003064685A2 (en) | 2003-08-07 |
| CA2473128A1 (en) | 2003-08-07 |
| MXPA04007353A (es) | 2004-11-26 |
| UY27634A1 (es) | 2003-07-31 |
| WO2003064685A3 (en) | 2003-12-24 |
| RU2004126440A (ru) | 2005-08-10 |
| PE20030816A1 (es) | 2003-10-28 |
| US20060228752A1 (en) | 2006-10-12 |
| KR20040077910A (ko) | 2004-09-07 |
| HRP20040669A2 (en) | 2005-06-30 |
| AR038334A1 (es) | 2005-01-12 |
| EP1472377A2 (en) | 2004-11-03 |
| BR0307257A (pt) | 2004-12-14 |
| PA8564401A1 (es) | 2004-03-26 |
| TW200302729A (en) | 2003-08-16 |
| US20030158187A1 (en) | 2003-08-21 |
| GT200300020A (es) | 2003-12-23 |
| JP2005515788A (ja) | 2005-06-02 |
| PL371731A1 (en) | 2005-06-27 |
| ZA200405516B (en) | 2005-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004005387D1 (de) | Zellenabstreifer | |
| DK3587433T3 (da) | Modificerede nukleotider | |
| AU2003254597A8 (en) | Dna chip based genetic typing | |
| DK1616178T3 (da) | Komparativ genomisk hybridisering | |
| DK1689869T3 (da) | Rekombinant mikroorganisme | |
| NO20033624D0 (no) | Matrise genekspresjon i chondrogenese | |
| DE502004008433D1 (de) | Wägezelle | |
| NO20043613L (no) | Genetisk polymorfi i preprotachykiningenet | |
| ITMI20022179A1 (it) | Il manopoliero | |
| SE0301110L (sv) | Forklift | |
| FR2842104B1 (fr) | Genes impliques dans la canitie precoce | |
| DK1680502T3 (da) | Rekombinant mikroorganisme | |
| AU2003294705A8 (en) | Ntsm gene | |
| EP1590432A4 (en) | DNA COMPOSITION AND ITS USE | |
| GB0229139D0 (en) | Gene polymorphisms | |
| GB2408980B (en) | Genetic reference materials | |
| AU2003263296A8 (en) | Dna repair enzymes | |
| NL1019697A1 (nl) | Stroomafnemer. | |
| SE0202308D0 (sv) | Genes | |
| EP1543018A4 (en) | GENEVA ASSOCIATED WITH LIVER CANCER | |
| GB0216016D0 (en) | Genetic testing | |
| SE0202408D0 (sv) | Polymorphism | |
| GB0317987D0 (en) | Genetic susceptibility | |
| GB0229119D0 (en) | Genetic susceptibility | |
| GB0313773D0 (en) | Gene |